Stay updated with breaking news from Syncona Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Quell Therapeutics Ltd ("Quell"), the world leader in the development of engineered T-regulatory (Treg) cell therapies for serious medical...
- Series B co-led by Jeito Capital, Ridgeback Capital Investments, SV Health Investors and Fidelity Management & Research Company LLC, alongside founding investor Syncona and includes a broad
/PRNewswire/ -- Quell Therapeutics Ltd ("Quell"), the world leader in the development of engineered T-regulatory (Treg) cell therapies for serious medical...
EXECUTIVE CHANGES: All change at Aura Energy amid ASX spin-out plan | Financial News
Investegate announcements from Syncona Limited, Autolus reports Q3 2021 Financial Results